155,732 Shares in West Pharmaceutical Services, Inc. $WST Bought by Border to Coast Pensions Partnership Ltd

Border to Coast Pensions Partnership Ltd acquired a new stake in West Pharmaceutical Services, Inc. (NYSE:WST) during the 3rd quarter, Holdings Channel reports. The fund acquired 155,732 shares of the medical instruments supplier’s stock, valued at approximately $40,853,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in WST. CYBER HORNET ETFs LLC bought a new stake in shares of West Pharmaceutical Services in the second quarter valued at about $25,000. SJS Investment Consulting Inc. grew its holdings in shares of West Pharmaceutical Services by 1,842.9% during the third quarter. SJS Investment Consulting Inc. now owns 136 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 129 shares in the last quarter. Vermillion & White Wealth Management Group LLC raised its position in West Pharmaceutical Services by 193.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 144 shares of the medical instruments supplier’s stock valued at $32,000 after buying an additional 95 shares during the last quarter. Pilgrim Partners Asia Pte Ltd acquired a new stake in West Pharmaceutical Services in the 3rd quarter valued at approximately $47,000. Finally, CVA Family Office LLC lifted its stake in West Pharmaceutical Services by 573.3% in the 2nd quarter. CVA Family Office LLC now owns 202 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 172 shares in the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.

West Pharmaceutical Services Stock Performance

Shares of WST opened at $237.09 on Thursday. The company has a market cap of $17.06 billion, a PE ratio of 35.12, a price-to-earnings-growth ratio of 3.18 and a beta of 1.18. The firm has a 50-day moving average of $265.64 and a 200-day moving average of $261.58. West Pharmaceutical Services, Inc. has a one year low of $187.43 and a one year high of $335.64. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.87 and a quick ratio of 2.18.

West Pharmaceutical Services Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 4th. Shareholders of record on Wednesday, January 28th were given a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Wednesday, January 28th. West Pharmaceutical Services’s payout ratio is 13.04%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on WST shares. Wall Street Zen upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating in a report on Saturday, December 20th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of West Pharmaceutical Services in a research report on Friday, January 9th. Barclays lifted their price target on shares of West Pharmaceutical Services from $275.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, October 27th. Evercore ISI reduced their price objective on shares of West Pharmaceutical Services from $390.00 to $320.00 and set an “outperform” rating for the company in a research note on Tuesday. Finally, UBS Group lifted their target price on West Pharmaceutical Services from $320.00 to $355.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Three investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $328.00.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a global developer and manufacturer of components, systems and services that enable the containment and delivery of injectable drugs. The company focuses on high-quality packaging and delivery solutions for the pharmaceutical and biotech industries, producing primary drug packaging components and specialized drug delivery devices used for vaccines, biologics and other injectable therapies. West is known for its elastomeric closures, seals and polymer components that maintain sterility and compatibility with sensitive drug formulations.

In addition to component manufacturing, West provides engineered delivery systems and support services across the product lifecycle.